Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Annales De Biologie Clinique|September 13, 2022
Review of nutritional components in Covid-19: what about micronutrients?Muriel Bost, Emmanuel Richard, Isabelle Redonnet-Vernhet, et al.
Therapeutic Drug Monitoring|March 5, 2025
Impact of UGT1A4 Polymorphisms on the Posaconazole Serum Trough Concentrations in Patients with Acute Myeloid Leukemia Receiving Delayed-Release TabletsFrançois Parant, Marie-Claude Gagnieu, Laurie Di-Pilla, et al.
Clinical Kidney Journal|October 30, 2020
Measurement of glomerular filtration rate in lung transplant recipients highlights a dramatic loss of renal function after transplantationNans Florens, Laurence Dubourg, Laurent Bitker, et al.
Therapeutic Drug Monitoring|April 22, 2024
Tacrolimus Monitoring in Liver Transplant Recipients, Posttransplant Cholestasis: A Comparative Between 2 Commercial Immunoassays and a Liquid Chromatography-Tandem Mass Spectrometry MethodFrançois Parant, Marie-Charlotte Delignette, Bruno Charpiat, et al.
BMC Infectious Diseases|March 22, 2014
Lower ribavirin biodisponibility in patients with HIV-HCV coinfection in comparison with HCV monoinfected patientsGiorgiana Hatu, François Bailly, Emmanuel Pourcelot, et al.
Nutrients|April 23, 2022
Vitamin D and COVID-19 Severity in Hospitalized Older Patients: Potential Benefit of Prehospital Vitamin D SupplementationFrançois Parant, Justin Bouloy, Julie Haesebaert, et al.
Nutrients|March 29, 2023
Minerals and Antioxidant Micronutrients Levels and Clinical Outcome in Older Patients Hospitalized for COVID-19 during the First Wave of the PandemicClément Lahaye, François Parant, Julie Haesebaert, et al.
British Journal of Clinical Pharmacology|August 21, 2023
Therapeutic drug monitoring and virological response at week 48 in a cohort of HIV-1-infected patients switching to dolutegravir/rilpivirine dual maintenance therapy (ANRS-MIE-BIRIDER study)Florian Lemaitre, Jennifer Lagoutte-Renosi, Marie-Claude Gagnieu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 18, 2025
Therapeutic Drug Monitoring of Long-Acting Cabotegravir and Rilpivirine in a National Cohort of People With Human Immunodeficiency Virus Type 1: First Results From the ANRS-MIE CARLAPOP StudyNadège Néant, Minh P Lê, Stéphane Bouchet, et al.
CPT: Pharmacometrics & Systems Pharmacology|May 22, 2026
External Evaluation of Population Pharmacokinetic Models of Cabotegravir, During Its Oral and Intramuscular Administration in HIV-Infected PatientsQuentin Renou, Nadège Néant, Alexandre Destere, et al.
Pageof 4